Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. (Q51798171)
Jump to navigation
Jump to search
scientific article published in July 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. |
scientific article published in July 2006 |
Statements
1 reference
Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. (English)
1 reference
Markku Laakso
1 reference
Laura Andrulionyte
1 reference
Paula Peltola
1 reference
Jean-Louis Chiasson
1 reference
STOP-NIDDM Study Group
1 reference
1 July 2006
1 reference
1 reference
55
1 reference
7
1 reference
2148-2152
1 reference
Identifiers
1 reference
1 reference